Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.4764
-0.0236 (-4.72%)
At close: Jan 30, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $918.45 thousand as of February 2, 2026.
Market Cap
918.45K
Enterprise Value
2.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.48
Market Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 918.45K, a decrease of -90.47%. That is a compound annual growth rate of -96.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 918.45K | -63.49% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halberd | 1.20M |
| CERo Therapeutics Holdings | 1.16M |
| Evofem Biosciences | 1.15M |
| Sigyn Therapeutics | 1.04M |
| Emmaus Life Sciences | 982.64K |
| Aibotics | 922.44K |
| Eastgate Biotech | 846.29K |
| EV Biologics | 839.50K |